Target Price Raised Ninefold on Biotech After Share Consolidation
June 05, 2018 at 04:00 AM EDT
Source: Streetwise Reports 06/05/2018 A Canaccord Genuity analyst provided an update on this late-stage Canadian life sciences firm targeting metastatic breast cancer. In a May 29 research report, analyst Neil Maruoka indicated Canaccord Genuity raised [...]
